Loading provider…
Loading provider…
Hematology & Oncology Physician in Jonesboro, GA
NPI: 1134106503Primary Practice Location
The Emory Clinic Inc
7813 Spivey Station Blvd, Jonesboro, GA
Primary Employer
NSH Cancer Institute Professional Services a LLC
atlantacancercare.com
HQ Phone
Get MBBS Lijo's Phone Numberphone_androidMobile
Get MBBS Lijo's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardGA State Medical License
GA State Medical License
2008 - 2026
MN State Medical License
2005 - 2009
IL State Medical License
2000 - 2008

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Advocate Health Care/Advocate Illinois Masonic Medical Center
Residency • Internal Medicine
2001 - 2005
All India Institute of Medical Sciences
Medical School
Until 1999
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Fellowship • Hematology and Medical Oncology
2005 - 2008
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 185 | 362 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 138 | 265 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 65 | 65 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 44 | 64 |
Invasive choriocarcinoma involving the major duodenal papilla.
Authors: Carey August
Publication Date: 2005-06
Authors: David Inwards, Ivana Micallef, Thomas Habermann, Luis Porrata, Svetomir Markovic, Patrick Johnston, Thomas Witzig, Stephen Ansell
Journal: Leuk Lymphoma
RENAL MEDULLARY CARCINOMA AND ABL GENE AMPLIFICATION
Authors: Steven Campbell
Journal: J Urol
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Veliparib, OTHER: Placebo Administration
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Lenalidomide, DRUG: Cyclophosphamide, DRUG: Prednisone, DRUG: Vincristine Sulfate, BIOLOGICAL: Rituximab, DRUG: Doxorubicin Hydrochloride